Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in New Haven, CT
NPI: 1043409691Primary Practice Location
YALE-NEW HAVEN HOSPITAL
35 Park St, New Haven, CT
Primary Employer
Yale Medicine
yalemedicine.org
HQ Phone
Get M.D. Michael's Phone NumberMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
Icahn School Of Medicine At Mount Sinai
icahn.mssm.edu
Medical School
Until 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 200 | 516 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 92 | 211 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 22 | 40 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 19 |
Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab.
Authors: LeClair, Jessica N, Merl, Man Yee, Cohenuram, Michael, Luon, Darren
Journal: Clin Lung Cancer
Publication Date: 2021-08-16
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, PROCEDURE: Positron Emission Tomography, BIOLOGICAL: Bevacizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, OTHER: Clinical Observation, OTHER: Quality-of-Life Assessment, PROCEDURE: Computed Tomography, PROCEDURE: Cystoscopy, PROCEDURE: CT Urography
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Division of Cancer Control, NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP), Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Weight Loss Intervention, OTHER: Health Education Program
